FCGR1A and inflammatory bowel disease: Only CD14+CD64+CD163−/dim, and more particularly CD163− but not CD163+ cells, accumulated in inflamed mucosa of IBD patients in proportions that correlate with endoscopic disease severity in CD, regardless treatment history, demographics and disease behavior or location [31,39].